AnserBio is an Israeli biomedical startup developing a novel approach to cancer treatment.
Our unique method of healthy p53 protein delivery into tumor cells is expected to benefit treatment of more than 60% of human cancers - alone or in combination with other agents.
The company is in preclinical stage.
Company Details
- Employees
- 8
- Founded
- 2017
- Address
- 47 Hataasiya, Nesher,haifa District 3688847,israel
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.anser-bio.com/
- Keywords
- Gsap.
- HQ
- Nesher, Haifa District
Anserbio Questions
Anserbio's website is https://www.anser-bio.com/
Anserbio's LinkedIn profile is https://il.linkedin.com/company/anserbio
Anserbio has
8 employees.
View email and phone details for 8
employees at Anserbio.
Anserbio's industry is
Biotechnology Research
Anserbio's top competitors are
Novocure,
Biogal Labs,
Cytora Stem,
Memed,
Biotav Shield Ltd.,
Teracyte Analytics,
Nanosono,
Gsap,
Pluri,
Adva Biotechnology.
Anserbio's categories are Biotechnology Research
Anserbio's founding year is 2017
